Skip to main content
. 2020 Feb;61(2):189–193. doi: 10.2967/jnumed.119.227207

TABLE 1.

Patient Characteristics

Patient no. Age (y) BW (kg) Dose (MBq) PSA (ng/mL) Primary staging Restaging Primary therapy Further prostate-specific therapy
1 64 67 120 0.7 x RPE No
2 67 73 132 8.5 x EBRT ADT until 5 mo before PET/CT
3 77 68 127 28 x NA No
4 59 73 124 0.3 x RPE No
5 76 70 143 14.7 EBRT ADT until 2 mo before PET/CT
6 63 74 160 96.7 x NA No
7 75 72 128 4 x RPE Under ADT
8 81 81 167 0.3 x RPE No
9 60 85 177 0.3 x RPE RTx and ADT until 3 y before PET/CT
10 69 81 156 1.5 x RPE No
11 71 100 192 0.2 x RPE No

PSA = prostate-specific antigen level; RPE = radical prostatectomy; EBRT = external-beam radiation therapy; ADT = androgen deprivation therapy; NA = not applicable; RTx = radiation therapy.